4 Hot Penny Stocks that Jumped Up 575% in March

penny stocks

Currently, global markets are experiencing a lot of volatility, which is triggering the massive sell-off we are witnessing as investors rush for cash to minimize losses. Various central bank governments have introduced stimulus measures to cushion the economy from the fallout caused by the spread of the coronavirus. Broader markets are fluctuating significantly in the wake of uncertainty caused by cOVID-19. However, amidst this chaos, there are significant opportunities for investors to cash in on several hot penny stocks.

Penny stocks usually trade below $5 per share, and although they are cheap, they nonetheless come with considerable risk. Any slight movement in the market can tip the scales for penny stocks, and investors will either make profits or lose their investment.

During these volatile times, various penny stocks have been raking in gains, while other stocks dropped into penny stock territory. Penny stocks tend to perform well during volatile times, with substantial breakouts over a short time period. Here are 4 hot penny stocks with significant gains in March:

4 Hot Penny Stocks: TOP Ships Inc. (NASDAQ:TOPS)

The first hot penny stock to watch is TOP Ships, which has surged more than 575% in the last three trading sessions. At the end of last week, the stock jumped over 200%, then continued gaining this week with another 130% leap. The trigger for the stock came after the company announced that it had converted 5,640 units of Series E Convertible Preferred stock from Family Trading Inc.

>> 5 Biotech Penny Stock Gainers on the Radar

The company said that it converted shares worth around $6.4 million. After the transaction, there are currently around 10,364 outstanding shares of Series E Convertible Preferred Stock.

4 Hot Penny Stocks: CytoDyn Inc. (OTCQB:CYDY)

hot penny stocks

Since last Thursday, CytoDyn stock is up 200% after the FDA gave its emergency Investigation New Drug a nod towards treating COVID-19 patients. On Monday, the company stated that three more critically ill COVID-19 patients had received treatment with its leronlimab drug, which now brings the number of patients treated to around ten.

Leronlimab is being administered under the emergency Investigation New Drug Application that the FDA issued recently. The drug can also be used for other indications, such as certain breast cancers and HIV. The company said the treatment is being carried at a New York hospital.

The stock is up another 12% on Tuesday.

4 Hot Penny Stocks: Tetraphase Pharmaceuticals (NASDAQ:TTPH)

Tetraphase Pharmaceuticals has surged more than 178% in the last two weeks after it hit a new low of $0.58 on March 18. This came following the announcement that AcelRx Pharmaceuticals (NASDAQ:ACRX) will acquire Tetraphase in an all-stock deal of around $14.4 million. Tetraphase shareholders will receive 0.6303 of AcelRx share for each Tetraphase share.

Recently, the company announced a $11.4 million loss or $2.75 per share in the fourth quarter. Revenue came in at $1.7 million in the quarter.  For the full-year, the company reported revenue of $7.4 million and a loss of $70.1 million or $22.85 per share.

4 Hot Penny Stocks: Athersys Inc. (NASDAQ:ATHX)

hot penny stocks

In the last two weeks, Athersys stock has jumped over 130%, and the gains continued into the this week. The company has announced that its partner in Japan, Healios KK, has exercised its warrant to acquire 4 million Athersys shares at $1.76. This represents a cash infusion of around $7.04 million to the company.

The company’s Fast-Tracked clinical program for the treatment of Acute Respiratory Distress Syndrome (ARDS) reported positive data in the second phase exploratory study employing MultiStem. Patients with ARDS who develop coronavirus are more likely to die than those without ARDS.

At the beginning of the year, BARDA reached out to Athersys and has labeled the MultiStem ADS Therapy as “highly relevant.” Talks are ongoing to bring the therapy to patients soon.

ATHX stock is now up by 7% at $2.78 and made a new 52-week high of $2.80.

Key Takeaway

As the spread of the coronavirus continues, markets are expected to remain volatile. Despite central banks announcing measures to cushion the economy, the sell-off experienced will likely continue. Will these 4 hot penny stocks remain hot? Or are things about to cool down? We can only wait and see.

>> Read More Penny Stock News

Featured image: Pixabay

Please See Disclaimer


Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of Microsmallcap.com or its officers. The author is wholly responsible for the validity of all statements. Microsmallcap.com was not involved in any aspect of the article preparation. The author was not paid by Market Jar Media Inc for this article. The author did not pay Microsmallcap.com to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Microsmallcap.com's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. Microsmallcap.com does not render general or specific investment advice. Any information on Microsmallcap.com should not be considered a recommendation to buy or sell any security. Microsmallcap.com does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.